Results 251 to 260 of about 129,126 (313)

Atopic Eczema

open access: yesJournal of the Royal College of Physicians of London, 1991
openaire   +2 more sources

Dupilumab treatment in children aged 6 months to 5 years with severe atopic dermatitis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The results of this French Early Access Program were consistent with those reported in dupilumab randomized clinical trials in children aged 6 months–5 years with moderate‐to‐severe AD. This research offers insights into the practical use of dupilumab in routine clinical practice.
Audrey Lasek   +9 more
wiley   +1 more source

Clinical evidence on integrated Chinese-Western medicine for atopic dermatitis. [PDF]

open access: yesIntegr Med Res
Luo X   +12 more
europepmc   +1 more source

Infantile Eczema

open access: yesInternational Journal of Clinical Practice, 1951
openaire   +2 more sources

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda   +31 more
wiley   +1 more source

Retrospective Assessment of Social Rejection Related to Atopic Dermatitis During Childhood and Adolescence: The Scars of Life—Eczema Study

open access: yes
International Journal of Dermatology, EarlyView.
Bruno Halioua   +24 more
wiley   +1 more source

Severity bands for atopic dermatitis measures: Analysis from adult dupilumab randomized clinical trials

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This analysis used a large clinical trial data set (>30,000 patient visits across >2800 patients) and novel statistical methodologies (including frequency cross‐over analysis and means based on spline regression) to develop severity threshold bands for clinician‐ and patient‐reported outcome measures for adults with moderate‐to‐severe atopic dermatitis.
Andreas Wollenberg   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy